TransMedics Group, Inc. Common Stock TMDX
$88.24
+27.92%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (7 Buy · 4 Hold · 0 Sell)
- Average Price Target
- $110.18
- Implied Upside
- +24.9%
- Price Target Range
- $77.00 – $175.00
- Analysts (12 mo)
- 11
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-11-06 | JP MorganAllen Gong |
Maintains | Neutral | $73 → $85 |
| 2026-11-06 | NeedhamMike Matson |
Maintains | Buy | $106 → $110 |
| 2026-11-06 | Canaccord GenuityJason Mills |
Maintains | Buy | $95 → $120 |
| 2026-10-13 | Canaccord GenuityJason Mills |
Maintains | Buy | $95 → $94 |
| 2026-10-07 | BarclaysChristopher Pasquale |
Initiates coverage on | Overweight | $120 |
| 2026-09-08 | TD CowenJoshua Jennings |
Reiterates | Buy | $120 |
| 2026-08-05 | UBSPatrick Wood |
Maintains | Neutral | $80 → $77 |
| 2026-08-05 | Piper SandlerMatt O'Brien |
Reiterates | Overweight | $120 → $100 |
| 2026-08-03 | NeedhamMike Matson |
Maintains | Buy | $142 → $106 |
| 2026-07-28 | UBS |
Initiates coverage on | Neutral | $80 |
| 2026-07-06 | Evercore ISI GroupDaniel Markowitz |
Maintains | Outperform | $100 → $90 |
| 2026-07-01 | TD CowenJoshua Jennings |
Reiterates | Buy | $120 |
| 2026-06-30 | Canaccord GenuityWilliam Plovanic |
Maintains | Buy | $124 |
| 2026-06-18 | StifelTom Stephan |
Maintains | Hold | $75 → $80 |
| 2026-05-26 | StifelTom Stephan |
Maintains | Hold | $85 → $75 |
| 2026-05-06 | Canaccord GenuityWilliam Plovanic |
Maintains | Buy | $152 → $124 |
| 2026-05-06 | TD CowenJoshua Jennings |
Maintains | Buy | $190 → $120 |
| 2026-05-06 | StifelThomas Stephan |
Maintains | Hold | $130 → $85 |
| 2026-05-06 | Piper SandlerMatt O'Brien |
Maintains | Overweight | $160 → $120 |
| 2026-05-06 | NeedhamMike Matson |
Maintains | Buy | $174 → $142 |
| 2026-04-06 | Evercore ISI GroupDaniel Markowitz |
Maintains | Outperform | $170 → $118 |
| 2026-03-09 | StifelThomas Stephan |
Maintains | Hold | $115 → $130 |
| 2026-02-25 | JP MorganAllen Gong |
Maintains | Neutral | $114 → $149 |
| 2026-02-25 | OppenheimerSuraj Kalia |
Maintains | Outperform | $150 → $175 |
| 2026-02-25 | Piper SandlerMatt O'Brien |
Maintains | Overweight | $140 → $160 |
| 2026-02-25 | Evercore ISI GroupDaniel Markowitz |
Maintains | Outperform | $155 → $170 |
| 2026-02-25 | NeedhamMike Matson |
Maintains | Buy | $166 → $174 |
| 2025-12-17 | Canaccord GenuityWilliam Plovanic |
Maintains | Buy | $147 → $148 |
| 2025-12-08 | NeedhamMike Matson |
Maintains | Buy | $148 → $166 |
| 2025-12-02 | Morgan StanleyPatrick Wood |
Maintains | Equal-weight | $123 → $135 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $88.24
- Market Cap
- $3.06 billion
- 52-Week Range
- $60.10 – $156.00
- Average Volume
- 1.02 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.